Suppr超能文献

凋亡相关蛋白在子宫内膜透明细胞癌发病机制中的表达

Expression of apoptosis-related proteins in the pathogenesis of endometrial clear cell carcinoma.

作者信息

Johnson Adam S, Fadare Oluwole

机构信息

Department of Pathology, Vanderbilt University Medical Center Nashville, TN, USA.

Department of Pathology, University of California San Diego San Diego, CA, USA.

出版信息

Int J Clin Exp Pathol. 2022 May 15;15(5):215-224. eCollection 2022.

Abstract

BACKGROUND

The balance of pro- and anti-apoptotic proteins plays a critical role in the regulation of cell death, and a disruption of this delicate balance may eventuate in carcinogenesis through a net reduction in apoptosis. Numerous chemotherapeutic strategies directly or indirectly target apoptotic pathways. However, a thorough assessment of apoptosis-related proteins has not previously been performed in endometrial clear cell carcinoma (CCC). This study aims to determine the significance of 9 apoptosis-related proteins in the pathogenesis of CCC as compared to non-neoplastic endometrium (NNE), low- and high-grade endometrial endometrioid carcinomas (LG-EEC, HG-EEC), and endometrial serous carcinoma (ESC).

MATERIALS AND METHODS

Expression of 6 anti-apoptotic proteins (Bcl-2, Bcl-xL, cFLIP, MCL-1, survivin, NFκB/p65) and three pro-apoptotic proteins (Bax, caspase-3, caspase-8) was assessed by immunohistochemistry on 49 CCC, 37 LG-EEC, 12 HG-ECC, 16 ESC, and 25 NNE in a tissue microarray. Objective IHC scores were assigned by an automated image capture system. Scores were then correlated with clinicopathologic values and each other.

RESULTS

Most notably, CCC showed significantly reduced expression of cFLIP relative to ESC, LG-EEC, HG-EEC, and NNE. CCC also showed significantly reduced expression of both Caspase 8 and NF-κB/p65 relative to ESC, HG-EEC, and NNE, but not LG-EEC. Bcl-2 and Bcl-xL showed reduced expression in CCC relative to all groups except ESC for Bcl-2 and NNE for Bcl-xL. There was no significant correlation between the proteins regarding expression levels. Within the CCC group, none of the proteins showed any significant association with patient age, myometrial invasion, final stage, lymphovascular invasion, disease-free or overall survival.

CONCLUSION

Our analysis of the expression and correlation patterns of a panel of apoptosis-related proteins suggests that the downregulation of cFLIP in CCC is significant relative to almost all other tissues, NNE, HG-EEC, and ESC. Other proteins, including Caspase 8, NF-κB/p65, Bcl-2 and Bcl-xL may also be significant. The regulation of apoptosis-related proteins in CCC may be important and may provide insight into chemoresistance in this enigmatic histotype. However, the paradoxical downregulation of both pro- and anti-apoptotic mediators suggests that additional study is needed to clarify the role of apoptotic mechanisms in CCC.

摘要

背景

促凋亡蛋白和抗凋亡蛋白的平衡在细胞死亡的调控中起着关键作用,这种微妙平衡的破坏可能通过细胞凋亡的净减少导致癌症发生。许多化疗策略直接或间接靶向凋亡途径。然而,此前尚未对子宫内膜透明细胞癌(CCC)中与凋亡相关的蛋白进行全面评估。本研究旨在确定9种与凋亡相关的蛋白在CCC发病机制中的意义,并与非肿瘤性子宫内膜(NNE)、低级别和高级别子宫内膜样癌(LG-EEC、HG-EEC)以及子宫内膜浆液性癌(ESC)进行比较。

材料与方法

通过免疫组织化学方法,在组织芯片上对49例CCC、37例LG-EEC、12例HG-ECC、16例ESC和25例NNE中6种抗凋亡蛋白(Bcl-2、Bcl-xL、cFLIP、MCL-1、survivin、NFκB/p65)和3种促凋亡蛋白(Bax, caspase-3, caspase-8)的表达进行评估。由自动图像采集系统分配客观的免疫组化评分。然后将评分与临床病理值以及各蛋白之间进行相关性分析。

结果

最显著的是,与ESC、LG-EEC、HG-EEC和NNE相比,CCC中cFLIP的表达显著降低。与ESC、HG-EEC和NNE相比,CCC中Caspase 8和NF-κB/p65的表达也显著降低,但与LG-EEC相比无显著差异。与除ESC(Bcl-2)和NNE(Bcl-xL)之外的所有组相比,CCC中Bcl-2和Bcl-xL的表达降低。这些蛋白的表达水平之间无显著相关性。在CCC组中,没有一种蛋白与患者年龄、肌层浸润、最终分期、淋巴管浸润、无病生存期或总生存期有任何显著关联。

结论

我们对一组凋亡相关蛋白的表达及相关性模式的分析表明,与几乎所有其他组织、NNE、HG-EEC和ESC相比,CCC中cFLIP的下调具有显著意义。其他蛋白,包括Caspase 8、NF-κB/p65、Bcl-2和Bcl-xL可能也具有显著意义。CCC中凋亡相关蛋白的调控可能很重要,并且可能为这种神秘组织学类型的化疗耐药性提供见解。然而,促凋亡和抗凋亡介质的矛盾下调表明,需要进一步研究以阐明凋亡机制在CCC中的作用。

相似文献

本文引用的文献

2
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.ESGO/ESTRO/ESP 子宫内膜癌管理指南。
Int J Gynecol Cancer. 2021 Jan;31(1):12-39. doi: 10.1136/ijgc-2020-002230. Epub 2020 Dec 18.
3
Targeting apoptotic caspases in cancer.靶向肿瘤细胞凋亡蛋白酶。
Biochim Biophys Acta Mol Cell Res. 2020 Jun;1867(6):118688. doi: 10.1016/j.bbamcr.2020.118688. Epub 2020 Feb 19.
7
FLIP as a therapeutic target in cancer.FLIP 作为癌症治疗靶点。
FEBS J. 2018 Nov;285(22):4104-4123. doi: 10.1111/febs.14523. Epub 2018 Jun 27.
8
Developing TRAIL/TRAIL death receptor-based cancer therapies.开发基于 TRAIL/TRAIL 死亡受体的癌症疗法。
Cancer Metastasis Rev. 2018 Dec;37(4):733-748. doi: 10.1007/s10555-018-9728-y.
9
Apoptosis: A Target for Anticancer Therapy.细胞凋亡:抗癌治疗的新靶点。
Int J Mol Sci. 2018 Feb 2;19(2):448. doi: 10.3390/ijms19020448.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验